Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products

Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products
Christopher R. Hall, John B. Reiss, Gregory J. Wartman, Co-authors
Food and Drug Law Journal

Partners John B. Reiss, Christopher R. Hall and Gregory J. Wartman co-wrote this article that examines FDA behavior, court decisions and developments that affect manufacturers of pharmaceuticals, medical devices and biotechnology products.

This is the fifth annual FDLJ article on the agency and, as federal regulations continue to evolve, it stresses the importance of affected companies instituting and maintaining effective compliance programs.